Molecular Therapy - Oncolytics
Journal Title
- Molecular Therapy - Oncolytics
ISSN
- E 2372-7705
Publisher
- Nature Publishing Group
Listed on(Coverage)
| JCR | 2016-2019 |
|---|---|
| SJR | 2015-2019 |
| CiteScore | 2016-2019 |
| SCIE | 2016-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| DOAJ | 2017-2021 |
| EMBASE | 2016-2020 |
OA Info.
| OA |
based on the information
|
|---|---|
| Keywords | cell biology, oncolytics, molecular therapy, gene therapy, cancer |
| Review Process | Blind peer review |
| Journal info. pages | |
| Licences | CC BY, CC BY-NC-ND |
| Copyrights | No |
| DOAJ Coverage |
|
| Subject(s) | Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- USA
Aime & Scopes
- Molecular Therapy — Oncolytics is an international, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality research that employs innovative molecular and cellular approaches that target cancer cells for destruction.